Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP435324.RA0ZMbHDIchC9ORKc3GLnR_13R2YdDjLi0bcBfrX91gjU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP435324.RA0ZMbHDIchC9ORKc3GLnR_13R2YdDjLi0bcBfrX91gjU130_assertion type Assertion NP435324.RA0ZMbHDIchC9ORKc3GLnR_13R2YdDjLi0bcBfrX91gjU130_head.
- NP435324.RA0ZMbHDIchC9ORKc3GLnR_13R2YdDjLi0bcBfrX91gjU130_assertion description "[Cyclin-dependent kinase inhibitor 2A (CDKN2A/p16), mesoderm-specific transcript, forkhead box M1, v-myb myeloblastosis viral oncogene homolog (avian)-like2 (v-Myb), minichromosome maintenance proteins 2, 4, and 5, cyclin B1, prostaglandin E synthase (PTGES), topoisomerase II alpha (TOP2A), ubiquitin-conjugating enzyme E2C, CD97 antigen, E2F transcription factor 1, and dUTP pyrophosphatase were among the most highly overexpressed genes in CVX when compared to NCK.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP435324.RA0ZMbHDIchC9ORKc3GLnR_13R2YdDjLi0bcBfrX91gjU130_provenance.
- NP435324.RA0ZMbHDIchC9ORKc3GLnR_13R2YdDjLi0bcBfrX91gjU130_assertion evidence source_evidence_literature NP435324.RA0ZMbHDIchC9ORKc3GLnR_13R2YdDjLi0bcBfrX91gjU130_provenance.
- NP435324.RA0ZMbHDIchC9ORKc3GLnR_13R2YdDjLi0bcBfrX91gjU130_assertion SIO_000772 15629771 NP435324.RA0ZMbHDIchC9ORKc3GLnR_13R2YdDjLi0bcBfrX91gjU130_provenance.
- NP435324.RA0ZMbHDIchC9ORKc3GLnR_13R2YdDjLi0bcBfrX91gjU130_assertion wasDerivedFrom befree-20140225 NP435324.RA0ZMbHDIchC9ORKc3GLnR_13R2YdDjLi0bcBfrX91gjU130_provenance.
- NP435324.RA0ZMbHDIchC9ORKc3GLnR_13R2YdDjLi0bcBfrX91gjU130_assertion wasGeneratedBy ECO_0000203 NP435324.RA0ZMbHDIchC9ORKc3GLnR_13R2YdDjLi0bcBfrX91gjU130_provenance.